Improved synthesis of a thienopyridine AMPK activator

ORGN 679

Jaekyoo Lee, jaekyoo@creagenbio.com, Venugopal N. Rao Neelagiri, venu@creagenbio.com, Hwa-Ok Kim, kim@creagenbio.com, and Raj SB Rajur, rrajur@creagenbio.com. Department of Chemistry, CreaGen Biosciences, Inc, 23 Rainin Road, Woburn, MA 01801
Thienopyridine 4 is a known AMPK activator. However, we recently were unable to repeat the reported synthesis of 4, using the procedure described in the patent literature, which led us to develop an improved procedure. The key features in the synthesis of thienopyridine 4 involve (1) preparation of tri-substituted thiophene 1; (2) coupling of 1 with cyanoacetic acid to produce amide 2; (3) base-induced cyclization of 2 to provide the fused thienopyridine 3; and finally, (4) installation of the 2-hydroxyphenyl group by Suzuki coupling to give the biphenyl-substituted thienopyridine 4. In particular, the choice of coupling conditions for the preparation of 2 and the choice of base for the cyclization of 2 to 3 are critical for the successful production of thienopyridine 4.